124500-61-4

Basic information

• Product Name: 4-(4-aminophenyl)-cyclohexanone
• Synonyms: 4-(4-aminophenyl)-cyclohexanone
• CAS NO: 124500-61-4
• Molecular Weight: 189.257
• Mol File: 124500-61-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 4-(4-aminophenyl)-cyclohexanone(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-aminophenyl)-cyclohexanone(124500-61-4)
• EPA Substance Registry System: 4-(4-aminophenyl)-cyclohexanone(124500-61-4)

Safety Data

• Hazardous Substances Data: 124500-61-4(Hazardous Substances Data)

Upstream product

• 124500-60-3 4-(4-nitrophenyl)cyclohexan-1-one 
• 4894-75-1 1-phenyl-4-cyclohexanone 

Downstream Products

• 105640-07-1 4-(4-hydroxyphenyl)cyclohexan-1-one 
• 178163-65-0 tert-butyl (4-(4-oxocyclohexyl)phenyl)carbamate 
• 1269802-53-0 1-formyl-2-chloro-3-hydroxymethylene-5-(4-diethylaminophenyl)cyclohexene 
• 1269802-74-5 2-[2-chloro-3-[2-(1,3-dihydro-1-octyl-3,3-dimethyl-2H-indolidine)ethyl-1-cyclohexyl]ethyl-5-(4-diethylamino)benzene]-1-octyl-3,3-dimethylindoline iodide 
• 1269802-73-4 2-[2-chloro-3-[2-(1,3-dihydro-1-hexyl-3,3-dimethyl-2H-indolidine)ethyl-1-cyclohexyl]ethyl-5-(4-diethylamino)benzene]-1-hexyl-3,3-dimethylindoline iodide 
• 1269802-72-3 2-[2-chloro-3-[2-(1,3-dihydro-1-butyl-3,3-dimethyl-2H-indolidine)ethyl-1-cyclohexyl]ethyl-5-(4-diethylamino)benzene]-1-butyl-3,3-dimethylindoline iodide 
• 1269802-71-2 2-[2-chloro-3-[2-(1,3-dihydro-1-propyl-3,3-dimethyl-2H-indolidine)ethyl-1-cyclohexyl]ethyl-5-(4-diethylamino)benzene]-1-propyl-3,3-dimethylindoline iodide 
• 1269802-69-8 2-[2-chloro-3-[2-(1,3-dihydro-1-ethyl-3,3-dimethyl-2H-indolidine)ethyl-1-cyclohexyl]ethyl-5-(4-diethylamino)benzene]-1-ethyl-3,3-dimethylindoline iodide 
• 1269802-67-6 2-[2-chloro-3-[2-(1,3-dihydro-1,3,3-trimethyl-2H-indolidine)ethyl]-1-cyclohexylethyl-5-(4-diethylamino)benzene]-1,3,3-trimethylindoline iodide 
• 1269802-51-8 4-(4-diethylaminophenyl)cyclohexanone 
• 954135-68-3 4-(4-amino-3-bromo-phenyl)-cyclohexanone 

Relevant articles and documents

INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY

The present disclosure relates to compounds that are capable of modulating the WNT/Beta-Catenin pathway. The disclosure further relates to methods of treating colorectal cancer and other WNT/Beta-Catenin mediated cancers.

INHIBITORS OF C-FMS KINASE

The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, es

Halobenzene liquid crystals

Compounds of the formula STR1 wherein X1 denotes fluorine or chlorine and X2 denotes hydrogen, fluorine or chlorine; R1 is 3E-alkenyl, 4-alkenyl, 2E-alkenyloxy or 3-alkenyloxy; n stands for the number 0 or 1; one of the groups Y1 and Y2 is a single covalent bond, --COO--, --OOC--, --CH2 CH2 --, --CH2 O-- or --OCH2 -- and the other of the groups Y1 and Y2 is a single covalent bond; and rings A1 and A2 each individually are substituted or unsubstituted trans-1,4-cyclohexylene, in which optionally 2 non-adjacent CH2 groups are replaced by oxygen, or substituted or unsubstituted 1,4-phenylene, in which optionally 1 CH group or 2 CH groups is/are replaced by nitrogen; with the proviso that X2 denotes fluorine or chlorine and/or Y1 or Y2 denotes --CH2 O-- or --OCH2 -- when simultaneously X1 is fluorine and R1 is 3E-alkenyl, and their use for liquid crystalline mixtures and electro-optical purposes.